Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,228.80
-12.00 (-0.97%)
Apr 20, 2026, 3:30 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1 trillion as of April 20, 2026. Its market cap has decreased by -17.88% in one year.
Market Cap
1.00T
Enterprise Value
902.01B
Revenue
279.67B
Ranking
n/a
PE Ratio
22.06
Stock Price
1,228.80
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.00T, an increase of 66,114.92%. That is a compound annual growth rate of 24.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.00T | -17.90% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.65T |
| Zydus Lifesciences | 949.83B |
| Mankind Pharma | 877.26B |
| Aurobindo Pharma | 804.99B |
| Alkem Laboratories | 667.41B |
| Glenmark Pharmaceuticals | 634.81B |
| Laurus Labs | 613.14B |
| Ipca Laboratories | 372.51B |